360 related articles for article (PubMed ID: 26810071)
21. Stages of granulovacuolar degeneration: their relation to Alzheimer's disease and chronic stress response.
Thal DR; Del Tredici K; Ludolph AC; Hoozemans JJ; Rozemuller AJ; Braak H; Knippschild U
Acta Neuropathol; 2011 Nov; 122(5):577-89. PubMed ID: 21935637
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains.
Westlake TM; Howlett AC; Bonner TI; Matsuda LA; Herkenham M
Neuroscience; 1994 Dec; 63(3):637-52. PubMed ID: 7898667
[TBL] [Abstract][Full Text] [Related]
23. Structural progression of Alzheimer's disease over decades: the MRI staging scheme.
Planche V; Manjon JV; Mansencal B; Lanuza E; Tourdias T; Catheline G; Coupé P
Brain Commun; 2022; 4(3):fcac109. PubMed ID: 35592489
[TBL] [Abstract][Full Text] [Related]
24. Cryptic exon incorporation occurs in Alzheimer's brain lacking TDP-43 inclusion but exhibiting nuclear clearance of TDP-43.
Sun M; Bell W; LaClair KD; Ling JP; Han H; Kageyama Y; Pletnikova O; Troncoso JC; Wong PC; Chen LL
Acta Neuropathol; 2017 Jun; 133(6):923-931. PubMed ID: 28332094
[TBL] [Abstract][Full Text] [Related]
25. Hippocampal Sclerosis but Not Normal Aging or Alzheimer Disease Is Associated With TDP-43 Pathology in the Basal Forebrain of Aged Persons.
Cykowski MD; Takei H; Van Eldik LJ; Schmitt FA; Jicha GA; Powell SZ; Nelson PT
J Neuropathol Exp Neurol; 2016 May; 75(5):397-407. PubMed ID: 26971127
[TBL] [Abstract][Full Text] [Related]
26. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease.
Whitwell JL; Weigand SD; Shiung MM; Boeve BF; Ferman TJ; Smith GE; Knopman DS; Petersen RC; Benarroch EE; Josephs KA; Jack CR
Brain; 2007 Mar; 130(Pt 3):708-19. PubMed ID: 17267521
[TBL] [Abstract][Full Text] [Related]
27. Loss of inositol 1,4,5-trisphosphate receptor sites and decreased PKC levels correlate with staging of Alzheimer's disease neurofibrillary pathology.
Kurumatani T; Fastbom J; Bonkale WL; Bogdanovic N; Winblad B; Ohm TG; Cowburn RF
Brain Res; 1998 Jun; 796(1-2):209-21. PubMed ID: 9689471
[TBL] [Abstract][Full Text] [Related]
28. Neuro-degeneration profile of Alzheimer's patients: A brain morphometry study.
Ramos Bernardes da Silva Filho S; Oliveira Barbosa JH; Rondinoni C; Dos Santos AC; Garrido Salmon CE; da Costa Lima NK; Ferriolli E; Moriguti JC
Neuroimage Clin; 2017; 15():15-24. PubMed ID: 28459000
[TBL] [Abstract][Full Text] [Related]
29. [An autopsied case of senile onset frontotemporal lobar degeneration].
Iwasaki Y; Mori K; Ito M; Deguchi A; Yoshida M
Rinsho Shinkeigaku; 2011 Jun; 51(6):426-9. PubMed ID: 21735736
[TBL] [Abstract][Full Text] [Related]
30. TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups.
Huie EZ; Escudero A; Saito N; Harvey D; Nguyen ML; Lucot KL; LaGrande J; Mungas D; DeCarli C; Lamar M; Schneider JA; Kapasi A; Rissman RA; Teich AF; Dugger BN
J Alzheimers Dis; 2023; 91(4):1291-1301. PubMed ID: 36617779
[TBL] [Abstract][Full Text] [Related]
31. GABA
Kwakowsky A; Calvo-Flores Guzmán B; Pandya M; Turner C; Waldvogel HJ; Faull RL
J Neurochem; 2018 Jun; 145(5):374-392. PubMed ID: 29485232
[TBL] [Abstract][Full Text] [Related]
32. Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy.
Koga S; Sanchez-Contreras M; Josephs KA; Uitti RJ; Graff-Radford N; van Gerpen JA; Cheshire WP; Wszolek ZK; Rademakers R; Dickson DW
Mov Disord; 2017 Feb; 32(2):246-255. PubMed ID: 28009087
[TBL] [Abstract][Full Text] [Related]
33. Characterization and distribution of [125I]epidepride binding to dopamine D2 receptors in basal ganglia and cortex of human brain.
Joyce JN; Janowsky A; Neve KA
J Pharmacol Exp Ther; 1991 Jun; 257(3):1253-63. PubMed ID: 1828505
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation-dependent TDP-43 antibody detects intraneuronal dot-like structures showing morphological characters of granulovacuolar degeneration.
Kadokura A; Yamazaki T; Kakuda S; Makioka K; Lemere CA; Fujita Y; Takatama M; Okamoto K
Neurosci Lett; 2009 Sep; 463(1):87-92. PubMed ID: 19539703
[TBL] [Abstract][Full Text] [Related]
35. Coexistence of TDP-43 and tau pathology in neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome).
Haraguchi T; Terada S; Ishizu H; Yokota O; Yoshida H; Takeda N; Kishimoto Y; Katayama N; Takata H; Akagi M; Kuroda S; Ihara Y; Uchitomi Y
Neuropathology; 2011 Oct; 31(5):531-9. PubMed ID: 21276079
[TBL] [Abstract][Full Text] [Related]
36. Functional interactions between entorhinal cortex and posterior cingulate cortex at the very early stage of Alzheimer's disease using brain perfusion single-photon emission computed tomography.
Hirao K; Ohnishi T; Matsuda H; Nemoto K; Hirata Y; Yamashita F; Asada T; Iwamoto T
Nucl Med Commun; 2006 Feb; 27(2):151-6. PubMed ID: 16404228
[TBL] [Abstract][Full Text] [Related]
37. TDP-43 pathology in multiple system atrophy: colocalization of TDP-43 and α-synuclein in glial cytoplasmic inclusions.
Koga S; Lin WL; Walton RL; Ross OA; Dickson DW
Neuropathol Appl Neurobiol; 2018 Dec; 44(7):707-721. PubMed ID: 29660838
[TBL] [Abstract][Full Text] [Related]
38. TDP-43 pathology in the population: prevalence and associations with dementia and age.
Keage HA; Hunter S; Matthews FE; Ince PG; Hodges J; Hokkanen SR; Highley JR; Dening T; Brayne C
J Alzheimers Dis; 2014; 42(2):641-50. PubMed ID: 25170584
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions.
Yokota O; Tsuchiya K; Arai T; Yagishita S; Matsubara O; Mochizuki A; Tamaoka A; Kawamura M; Yoshida H; Terada S; Ishizu H; Kuroda S; Akiyama H
Acta Neuropathol; 2009 Apr; 117(4):429-44. PubMed ID: 19194716
[TBL] [Abstract][Full Text] [Related]
40. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.
Kaufman SK; Del Tredici K; Thomas TL; Braak H; Diamond MI
Acta Neuropathol; 2018 Jul; 136(1):57-67. PubMed ID: 29752551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
